Key takeaways:
- Treat obesity as the root cause of diabetes.
- By integrating obesity care into diabetes prevention programs, clinicians can support sustained weight loss, reduce metabolic risk and improve long-term outcomes.
Obesity and type 2 diabetes are deeply interconnected. Yet, many diabetes prevention programs fail to adequately treat obesity as the chronic, relapsing disease that it is.
While lifestyle interventions remain foundational, decades of evidence and newer therapies have made it clear that obesity treatment is one of the most effective ways to prevent type 2 diabetes.
To achieve more meaningful, sustained reductions in diabetes risk, it is important to rethink how prevention programs are designed. That means going beyond coaching alone and building in medical, behavioral and surgical tools that address the full complexity of obesity.
What evidence tells us
Obesity treatment significantly reduces the risk for developing type 2 diabetes. Even modest, sustained weight loss of 5% to 10% can substantially lower diabetes risk.
Landmark trials like the Diabetes Prevention Program showed that lifestyle-driven weight loss reduced diabetes incidence by 58% at 3 years.
Newer therapies such as GLP-1 and dual glucose-dependent insulinotropic polypeptide/GLP-1 receptor agonists show even greater reductions in diabetes progression, independent of lifestyle change. Bariatric surgery has also been shown to dramatically lower diabetes incidence over decades of follow-up.
These therapies highlight the need to move beyond lifestyle alone and treat obesity as a medical condition requiring a tailored and multipronged approach.
Read more: Integrating diabetes prevention into obesity treatment: A new model for better outcomes
Source: Healio